Overview

Early Prediction of Fluoxetine Response

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to identify what degree of symptom changes during the early weeks could be used to predict eventual nonresponse at week 6 among depressive inpatients taking fluoxetine.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kaohsiung Kai-Suan Psychiatric Hospital
Treatments:
Fluoxetine
Criteria
Inclusion Criteria:

- diagnosis of major depressive disorder

- HAM-D-17 ≧17

- written informed consent

Exclusion Criteria:

- Comorbid of substance abuse/dependence

- Comorbid with mental disorders due to general medical conditions

- Past history of treatment-resistant depression

- Severe physical problems

- pregnant women

- lactation